ArticleLeukemia2002
Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML.
Article in Leukemia, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- The roles of ubiquitination in AML.Annals of hematology · 2024Review
- Article
- Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia.International journal of molecular sciences · 2023Review
- Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.Frontiers in genetics · 2020Review
- Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia.Oncology letters · 2017Article
- Simulated annealing based algorithm for identifying mutated driver pathways in cancer.BioMed research international · 2014Article
- Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms.Blood cancer journal · 2012Article
- Finding driver pathways in cancer: models and algorithms.Algorithms for molecular biology : AMB · 2012Article
- De novo discovery of mutated driver pathways in cancer.Genome research · 2012Article
- Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.Iranian biomedical journal · 2012Article
- Cell cycle control in acute myeloid leukemia.American journal of cancer research · 2012Article
- Contribution of an aged microenvironment to aging-associated myeloproliferative disease.PloS one · 2012Article
- Myelodysplastic syndromes: an update on molecular pathology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2010Review
- Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.Leukemia · 2010Article
- Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates.Leukemia · 2009Article
- Article
- High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia.Leukemia · 2009Article
- Applications of microarray technology to Acute Myelogenous Leukemia.Cancer informatics · 2009Article
- NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features.Leukemia · 2008Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
11960359What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.